Friday, October, 23, 2009
Alternative Schizophrenia Treatments
October 03, 2008
The U.S. Food and Drug Administration has approved Risperdal for
the treatment of schizophrenia and bipolar disorder in children and
teens. Risperdal is now the only approved med for the treatment of
schizophrenia in youths, and it joins lithium as an approved
treatment for teen bipolar disorder.
Read more »
Expert & Community Posts
By Paul Ballas
,
Health Expert
Recently, the medication Abilify (aripiprazole) was approved by the FDA for the...
Read more »
By Christina Bruni
,
Health Expert
Recently, I had the opportunity to talk with a student at Pratt Institute, my alma mater. She was...
Read more »
By Jerry Kennard
,
Health Expert
One of the first targeted treatments for schizophrenia has been announced in this month's American...
Read more »
By Teri Robert
,
Health Expert
Today, the FDA approved Risperdal for the treatment of schizophrenia in adolescents 13 to 17...
Read more »
By Robin Cunningham
,
Health Expert
Being a biological scientist by training with graduate work in psychology, and having developed...
Read more »
Health Guide
In 2007, the Food and Drug Administration approved risperidone (Risperdal) and aripiprazole (Abilify) for treatment schizophrenia in teenagers. These drugs are the first...
Read more »
...generally used for schizophrenia:Typical antipsychotics. Until recently, these drugs were the mainstay
treatments for schizophrenia. They include haloperidol (Haldol), chlorpromazine (Thorazine),...
Read more »
Bipolar disorder is a recurrent disease that can be unpredictable. The major goals of treatment are to:Treat and reduce the severity of acute episodes of mania or depression when they...
Read more »
LithiumLithium (Carbolith, Duralith, Lithobid, Lithizine, Eskalith, Lithane) is one of the standard mood stabilizing drugs for bipolar disorder. Lithium is extremely helpful for most...
Read more »
Paranoid schizophrenia Treatment Support Groups Expectations (prognosis) Complications Calling your health care provider ...
Read more »
Related News
February 22, 2007
By Lucy Williams, Ivanhoe Health Correspondent ORLANDO, Fla. (Ivanhoe Newswire) -- Some patients undergoing treatment for mental illness gain so...
Read summary »
October 02, 2008
The Food and Drug Administration (FDA) has approved extended-release Invega for the treatment of schizophrenia. The FDA made the decision after...
Read summary »
October 02, 2008
Drugmaker AstraZeneca is seeking approval from the Food and Drug Administration for a once-daily formula of Seroquel. Seroquel is currently approved...
Read summary »
September 19, 2008
A study suggests that immaturity in the areas of the brain that control memory and mood may lead to schizophrenia. In a study involving mice that...
Read summary »
August 10, 2009
An expert panel that advises the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend a new drug for bipolar I disorder and...
Read summary »